İTÜ ARI Teknokent A.Ş., Boğaziçi University Center for Targeted Therapy Technologies (CT³), and the Istanbul Health Industry Cluster (ISEK) have joined forces under the MedTech & BioTech Program.
Through the tripartite cooperation protocol signed in Istanbul on September 1, 2026, the aim is to support innovative startups in the MedTech and BioTech sectors, accelerate productization and commercialization processes, and integrate inventions developed at universities—but not yet turned into products—into the entrepreneurship ecosystem.
Within the scope of this collaboration, joint efforts will also be carried out to:
- Support the technology-focused entrepreneurial journeys of young people,
- Create a sustainable ecosystem that strengthens the process from idea to product,
- Foster a stronger connection between academic knowledge/technology and the world of entrepreneurship,
- Develop a robust community that brings together the entrepreneurs and investors of the future.
At the inaugural meeting held following the signing of the protocol by Prof. Dr. Attila Dikbaş, Prof. Dr. Cengizhan Öztürk, and Dr. Volkan Özguz, the initial steps of the collaboration were outlined, and a Joint Executive Board was established.
As Boğaziçi CT³, we continue to expand collaborations that support the transformation of scientific knowledge and research infrastructure into innovative products, technologies, and startups.
From science to technology, from idea to product, from product to startup…
